Figure 1
From: Pathway-based gene signatures predicting clinical outcome of lung adenocarcinoma
Using HMGB1/RAGE signalling pathway-based signatures as prognosis predictor, Kaplan-Meier survival analysis of patients with lung adenocarcinoma were performed in all four training datasets (CAN/DF, HLM, UK, MSK) and in the two validation cohorts (GSE14814 and GSE1321).
